Table 2

 Baseline blood levels before CPAP treatment

Cardiovascular markerPre subtherapeutic CPAP(n = 112)Pre therapeutic CPAP(n = 108)Normal controls
Values are mean (SD).
†No laboratory reference range as new test.
‡Compared with all OSA patients before randomisation.
¶Non-fasting levels.
FXIIa (ng/ml)†2.0 (1.2), n = 192.1 (1.0), n = 261.7 (0.3), n = 21
p<0.001‡
FVIIa (mU/ml)†111.2 (40.8), n = 1893.7 (50.7), n = 2632.0 (14.0), n = 32
p<0.001‡
s-Psel (ng/ml)†53.0 (32.3), n = 4658.2 (41.9), n = 4729.5 (10.5), n = 22
p = 0.005‡
TAT (μg/l)†12.3 (24.1), n = 2012.3 (25.1), n = 262.6 (1.4), n = 29
p = 0.007‡
Laboratory reference ranges
vWFAg (IU/dl)120.8 (50.5), n = 46129.3 (51.2), n = 4450–200
Fibrinogen (g/l)2.6 (0.6), n = 202.4 (0.5), n = 261.5–4.0
FVII (IU/dl)118.4 (20.8), n = 20119.5 (28.3), n = 2650–200
FVIII (IU/dl)124.1 (29.3), n = 20130.8 (31.6), n = 2650–200
FXII (IU/dl)102.9 (29.5), n = 20124.2 (36.8), n = 2650–200
Homocysteine (μmol/l)9.7 (3.6), n = 499.9 (3.2), n = 525–15
Cholesterol (mmol/l)5.7 (1.1), n = 1075.6 (1.3), n = 1063.9–7.8
Triglyceride (mmol/l)2.6 (1.9)¶, n = 493.3 (2.5)¶, n = 520.55–1.9 (fasting)